Pancreatic Cancer Biomarker Study

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

October 31, 2024

Conditions
Pancreatic Adenocarcinoma
Trial Locations (1)

49503

Mercy Health Saint Mary's Hospital, Grand Rapids

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Spectrum Health Hospitals

OTHER

collaborator

Mercy Health

OTHER

lead

Van Andel Research Institute

OTHER